Cost-outcome description of clinical pharmacist interventions in a university teaching hospital

Hdl Handle:
http://hdl.handle.net/10147/317075
Title:
Cost-outcome description of clinical pharmacist interventions in a university teaching hospital
Authors:
Gallagher, James; Byrne, Stephen; Woods, Noel; Lynch, Deirdre; McCarthy, Suzanne
Citation:
Gallagher J et al. BMC Health Services Research. 2014 Apr 17;14(1):177
Journal:
BMC health services research
Issue Date:
17-Apr-2014
URI:
http://dx.doi.org/10.1186/1472-6963-14-177; http://hdl.handle.net/10147/317075
Abstract:
Abstract Background Pharmacist interventions are one of the pivotal parts of a clinical pharmacy service within a hospital. This study estimates the cost avoidance generated by pharmacist interventions due to the prevention of adverse drug events (ADE). The types of interventions identified are also analysed. Methods Interventions recorded by a team of hospital pharmacists over a one year time period were included in the study. Interventions were assigned a rating score, determined by the probability that an ADE would have occurred in the absence of an intervention. These scores were then used to calculate cost avoidance. Net cost benefit and cost benefit ratio were the primary outcomes. Categories of interventions were also analysed. Results A total cost avoidance of €708,221 was generated. Input costs were calculated at €81,942. This resulted in a net cost benefit of €626,279 and a cost benefit ratio of 8.64: 1. The most common type of intervention was the identification of medication omissions, followed by dosage adjustments and requests to review therapies. Conclusion This study provides further evidence that pharmacist interventions provide substantial cost avoidance to the healthcare payer. There is a serious issue of patient’s regular medication being omitted on transfer to an inpatient setting in Irish hospitals.
Language:
en
Keywords:
PHARMACIST; COST EFFCTIVENESS; HOSPITAL

Full metadata record

DC FieldValue Language
dc.contributor.authorGallagher, Jamesen_GB
dc.contributor.authorByrne, Stephenen_GB
dc.contributor.authorWoods, Noelen_GB
dc.contributor.authorLynch, Deirdreen_GB
dc.contributor.authorMcCarthy, Suzanneen_GB
dc.date.accessioned2014-05-16T11:54:51Z-
dc.date.available2014-05-16T11:54:51Z-
dc.date.issued2014-04-17-
dc.identifier.citationGallagher J et al. BMC Health Services Research. 2014 Apr 17;14(1):177en_GB
dc.identifier.urihttp://dx.doi.org/10.1186/1472-6963-14-177-
dc.identifier.urihttp://hdl.handle.net/10147/317075-
dc.description.abstractAbstract Background Pharmacist interventions are one of the pivotal parts of a clinical pharmacy service within a hospital. This study estimates the cost avoidance generated by pharmacist interventions due to the prevention of adverse drug events (ADE). The types of interventions identified are also analysed. Methods Interventions recorded by a team of hospital pharmacists over a one year time period were included in the study. Interventions were assigned a rating score, determined by the probability that an ADE would have occurred in the absence of an intervention. These scores were then used to calculate cost avoidance. Net cost benefit and cost benefit ratio were the primary outcomes. Categories of interventions were also analysed. Results A total cost avoidance of €708,221 was generated. Input costs were calculated at €81,942. This resulted in a net cost benefit of €626,279 and a cost benefit ratio of 8.64: 1. The most common type of intervention was the identification of medication omissions, followed by dosage adjustments and requests to review therapies. Conclusion This study provides further evidence that pharmacist interventions provide substantial cost avoidance to the healthcare payer. There is a serious issue of patient’s regular medication being omitted on transfer to an inpatient setting in Irish hospitals.-
dc.language.isoenen
dc.subjectPHARMACISTen_GB
dc.subjectCOST EFFCTIVENESSen_GB
dc.subjectHOSPITALen_GB
dc.titleCost-outcome description of clinical pharmacist interventions in a university teaching hospitalen_GB
dc.identifier.journalBMC health services researchen_GB
dc.language.rfc3066en-
dc.rights.holderJames Gallagher et al.; licensee BioMed Central Ltd.-
dc.description.statusPeer Reviewed-
dc.date.updated2014-05-14T19:05:43Z-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.